A Meal-based Comparison of Protein Quality, Complementary Proteins and Muscle Anabolism
MAPP
1 other identifier
interventional
23
1 country
1
Brief Summary
To highlight the importance of protein quality rather than the total protein content of a meal, the investigators will demonstrate that unlike high quality proteins, a single meal containing 30 g of an incomplete protein source does not stimulate skeletal muscle protein synthesis. Secondly, the investigators will directly challenge a prevalent, but untested, assertion that has the potential to negatively impact health. The goal is to demonstrate that complementary plant-proteins (i.e., two or more incomplete protein sources) must be consumed at the same meal to stimulate protein synthesis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2019
CompletedFirst Posted
Study publicly available on registry
January 25, 2019
CompletedStudy Start
First participant enrolled
March 26, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 21, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 21, 2021
CompletedApril 29, 2021
December 1, 2020
1.8 years
January 22, 2019
April 27, 2021
Conditions
Outcome Measures
Primary Outcomes (11)
Acute muscle protein synthesis: PRO-A
Muscle protein synthesis response to PRO-A breakfast meal (%/h)
3 hours after consuming meal
Acute muscle protein synthesis: PRO-B
Muscle protein synthesis response to PRO-B breakfast meal (%/h)
3 hours after consuming meal
Acute muscle protein synthesis: PRO-C
Muscle protein synthesis response to PRO-C breakfast meal (%/h)
3 hours after consuming meal
Acute muscle protein synthesis: CON
Muscle protein synthesis response to CON breakfast meal (%/hour)
3 hours after consuming meal
24-hour muscle protein synthesis: PRO-A
Muscle protein synthesis response to PRO-A diet over 24 hours (%/hour)
Approximately 24 hours
24-hour muscle protein synthesis: PRO-B
Muscle protein synthesis response to PRO-B diet over 24 hours (%/hour)
Approximately 24 hours
24-hour muscle protein synthesis: PRO-C
Muscle protein synthesis response to PRO-C diet over 24 hours (%/hour)
Approximately 24 hours
Blood amino acid response to diet: PRO-A
Blood samples will be drawn to measure amino acid concentrations response to PRO-A breakfast (µmol/L)
Approximately 5 hours
Blood amino acid response to diet: PRO-B
Blood samples will be drawn to measure amino acid concentrations response to PRO-B breakfast (µmol/L)
Approximately 5 hours
Blood amino acid response to diet: PRO-C
Blood samples will be drawn to measure amino acid concentrations response to PRO-B C breakfast (µmol/L)
Approximately 5 hours
Blood amino acid response to diet: CON
Blood samples will be drawn to measure amino acid concentrations response to CON breakfast (µmol/L)
Approximately 5 hours
Secondary Outcomes (16)
Blood glucose response to diet: PRO-A
Approximately 24 hours
Blood glucose response to diet: PRO-B
Approximately 24 hours
Blood glucose response to diet: PRO-C
Approximately 24 hours
Blood glucose response to diet: CON
Approximately 5 hours
Appetite and Hedonic Questionnaire: PRO-A
Approximately 8 hours
- +11 more secondary outcomes
Study Arms (4)
PRO-A
EXPERIMENTALBeef protein
PRO-B
EXPERIMENTALComplementary proteins at each meal
PRO-C
EXPERIMENTALComplementary proteins over 24 hours
CON
NO INTERVENTIONLow protein (\<5 g) meal
Interventions
Eligibility Criteria
You may qualify if:
- All races and ethnic backgrounds
- Men and women, age 45-60 years
You may not qualify if:
- Able and willing to provide informed consent
- Ability to speak and read English (\* the study procedures, e.g., muscle biopsy, duration of each acute study, e.g. overnight stay; and multiple dietary questionnaires require sound written and spoken English)
- Sarcopenia (defined by: European Working Group on Sarcopenia in Older People, EWGSOP (44))
- Clinically significant heart disease (e.g. New York Heart Classification greater than grade II; ischemia)
- Peripheral vascular disease
- Pulmonary disease
- History of systemic or pulmonary embolus
- Uncontrolled blood pressure (systolic BP\>170, diastolic BP\>95 mmHg)
- Impaired renal function (creatinine \>1.5 mg/dl)
- Anemia (hematocrit \<33)
- Untreated thyroid disease (abnormal TSH)
- A recent history (\<12 months) of GI bleed
- Diabetes mellitus or other untreated endocrine or metabolic disease
- Electrolyte abnormalities
- Any history of stroke, hypo- or hyper-coagulation disorders
- +10 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Unversity of Texas Medical Branch
Galveston, Texas, 77555, United States
Related Publications (1)
Arentson-Lantz EJ, Von Ruff Z, Connolly G, Albano F, Kilroe SP, Wacher A, Campbell WW, Paddon-Jones D. Meals Containing Equivalent Total Protein from Foods Providing Complete, Complementary, or Incomplete Essential Amino Acid Profiles do not Differentially Affect 24-h Skeletal Muscle Protein Synthesis in Healthy, Middle-Aged Women. J Nutr. 2024 Dec;154(12):3626-3638. doi: 10.1016/j.tjnut.2024.10.010. Epub 2024 Oct 11.
PMID: 39396760DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Doug Paddon-Jones, PhD
University of Texas
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 22, 2019
First Posted
January 25, 2019
Study Start
March 26, 2019
Primary Completion
January 21, 2021
Study Completion
January 21, 2021
Last Updated
April 29, 2021
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share